FDA approves laparoscopic ultrasound probe

Article

A new laparoscopic ultrasound probe recently cleared for market by the FDA is being offered as an option on Endocare, Inc.'s Cryocare CS System.

A new laparoscopic ultrasound probe recently cleared for market by the FDA is being offered as an option on Endocare, Inc.'s Cryocare CS System. The four-way articulating linear array of the 7.0-Hz probe uses color Doppler for more precise, clear images during keyhole surgery, the company says. The probe plugs directly into the system and is controlled through the keyboard. The Cryocare CS System is a fully integrated cryosurgical planning, placement, and treatment system designed to deliver targeted cryoablation in treating prostate and kidney cancers.

Related Videos
Daniel J. Heidenberg, MD, answers a question during a Zoom video interview
African American patient explaining issues to Asian doctor using tablet | Image Credit: © rocketclips - stockadobe.com
Todd M. Morgan, MD, answers a question during a Zoom video interview
3D illustration of prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com
Group of doctors reading a document | Image Credit: © Flamingo Images - stock.adobe.com
Brian T. Helfand, MD, and Matthew Smith, MD, PhD, experts on prostate cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.